BBS-Bioactive Bone Substitutes Oyj Future Growth
Future criteria checks 0/6
BBS-Bioactive Bone Substitutes Oyj is forecast to grow earnings and revenue by 28.3% and 77.4% per annum respectively while EPS is expected to grow by 31.3% per annum.
Key information
28.3%
Earnings growth rate
31.3%
EPS growth rate
| Biotechs earnings growth | 31.0% |
| Revenue growth rate | 77.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 27 Feb 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 3 | -3 | -3 | -3 | 1 |
| 12/31/2024 | 1 | -4 | -4 | -4 | 1 |
| 12/31/2023 | N/A | -4 | -3 | -3 | 1 |
| 12/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2020 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 6/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2020 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2019 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2019 | N/A | -1 | -2 | -2 | N/A |
| 12/31/2018 | N/A | 0 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -1 | -2 | -2 | N/A |
| 6/30/2018 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -4 | -2 | -1 | N/A |
| 12/31/2017 | N/A | -4 | -1 | -1 | N/A |
| 12/31/2016 | N/A | -1 | -1 | -1 | N/A |
| 12/31/2015 | N/A | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BONEHU0123 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BONEHU0123 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BONEHU0123 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BONEHU0123 is forecast to have no revenue next year.
High Growth Revenue: BONEHU0123 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BONEHU0123's Return on Equity is forecast to be high in 3 years time